Ceramide EOP at a Glance
- Type of ceramide found naturally in skin
- Helps improve skin’s barrier strength and hydration
- Works optimally when combined with other ceramides
- Deemed a safe cosmetic ingredient by the Cosmetic Ingredient Review Expert Panel
Ceramide EOP Description
Ceramide EOP belongs to a larger group of ceramides that are found naturally in skin as long chains of lipids (fats). The “P” indicates the ceramide contains phytosphinogosine, while the “EO” refers to the type of fatty acid correlated with the ingredient.
Healthy skin is typically made up of 50% ceramides, but as the levels of ceramides decrease over time, skin’s barrier becomes weaker, making it more vulnerable to external stressors and dehydration. As a skin care ingredient, topical application of ceramide EOP can step in to help fill this gap and strengthen skin’s barrier against external stimuli. This works best when combined with other ceramides + replenishing ingredients like fatty acids and cholesterol. Together, these lipid mixtures improve skin’s hydration, resiliency, and suppleness.
The Cosmetic Ingredient Review Expert Panel’s 2020 assessment concluded that ceramide ingredients are safe in cosmetics in the present practices of use. Their survey data looked at personal care products containing concentrations between 0.000001-0.01% of ceramide EOP. Ceramides used in skin care are typically synthetic (aka lab engineered.) They can also be sourced naturally from plants.
This ingredient may also be listed as ceramide 1.
Ceramide EOP References
International Journal of Toxicology, 2020, pages 5S-25S
International Journal of Molecular Sciences, August 2019, pages 1-15
Biochimica et Biophysica Acta, October 2014, pages 2473-2483
Journal of the American Academy of Dermatology, July 2014, pages 177-184
Journal of Lipid Research, July 2008, pages 1,466-1,476
Journal of Lipid Research, September 2007, pages 1936-1943
American Journal of Clinical Dermatology, 2003, pages 107-129
Journal of Investigative Dermatology, November 2001, pages 1,126-1,136
Skin Pharmacology and Applied Skin Physiology, September-October 2001, pages 261-271